Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
63.6M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
39.2M
-
Shares change
-
-2.01M
-
Total reported value, excl. options
-
$851M
-
Value change
-
-$43.7M
-
Put/Call ratio
-
2.84
-
Number of buys
-
53
-
Number of sells
-
-47
-
Price
-
$21.67
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q3 2020
129 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q3 2020.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.2M shares
of 63.6M outstanding shares and own 61.71% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (5.14M shares), NEA Management Company, LLC (4.91M shares), JANUS HENDERSON GROUP PLC (4.39M shares), PRIMECAP MANAGEMENT CO/CA/ (3.57M shares), BlackRock Inc. (2.64M shares), BAKER BROS. ADVISORS LP (2.47M shares), WELLINGTON MANAGEMENT GROUP LLP (2.37M shares), FEDERATED HERMES, INC. (2.27M shares), MPM ASSET MANAGEMENT LLC (1.91M shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.9M shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.